Allelic Variation in the D4 Dopamine Receptor (DRD4) Gene Does Not Predict Response to Clozapine

Archives of General Psychiatry

Volumn 51, Issue 11, 1994, Pages 912-917

  Rao, Peter A ^a,b,d   Pickar, David ^c   Gejman, Pablo V ^c   Ram, Anca ^c   Gershon, Elliot S ^c   Gelernter, Joel ^a,b  

^a Department of Psychiatry West Haven ^*  (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^d Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; DOPAMINE RECEPTOR; FLUPHENAZINE; RECEPTOR SUBTYPE; DOPAMINE 2 RECEPTOR; DOPAMINE 4 RECEPTOR; DRD4 PROTEIN, HUMAN; PLACEBO;

ALLELE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE FREQUENCY; HUMAN; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; SCHIZOIDISM; SCHIZOPHRENIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; GENETIC VARIABILITY; GENETICS; GENOTYPE; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PROBABILITY; PSYCHOSIS; TREATMENT OUTCOME;

ALLELES; BASE SEQUENCE; CLOZAPINE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; GENE FREQUENCY; GENOTYPE; HUMANS; MOLECULAR SEQUENCE DATA; PLACEBOS; PROBABILITY; PSYCHOTIC DISORDERS; RECEPTORS, DOPAMINE; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D4; SCHIZOPHRENIA; TREATMENT OUTCOME; VARIATION (GENETICS);

EID: 0028172045     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archpsyc.1994.03950110072009     Document Type: Article

References (41)

1. Karno M and Norquist GS. Schizophrenia: epidemiology. In: Kaplan HI, Sadock BJ, eds. Comprehensive Textbook of Psychiatry. 5th ed. Baltimore, Md: Williams & Wilkins; 1989: 699–705.
2. Creese I, Burt DR, Snyder SH. Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science. 1976;192: 481–483.
3. Rao PA, Molinoff P, Joyce JN. Ontogeny of dopamine D, and D2 receptor subtypes in rat basal ganglia: a quantitative autoradiographic study. Dev Brain Res. 1991:60: 161–177.
4. Seeman P. Dopamine receptors and the dopamine hypothesis of schizophrenia. Synapse. 1987;1: 133–152.
5. Sokoloff P, Giros B, Martres M-P, Bouthenet M-L, Schwartz J-C. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature. 1990;347: 146–151.
6. Van Tol HHM, Bunzow JR, Guan H-C, et al. Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature. 1991;350: 610–614.
7. Sunahara RK, Guan H-C, O'Dowd BF, et al. Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1. Nature. 1991;350: 614–619.
8. O'Dowd BF, Hnatowich M, Lefkowitz RL. Adrenergic and related G protein coupled receptors, structure and function. In: Dulbecco R, ed. Encyclopedia of Human Biology. Orlando, Fla: Academic Press Inc; 1991;1: 81–92.
9. Deuth AY, Moghaddam B, Innis RB, et al. Mechanisms of action of atypical antipsychotics drugs: implications for novel therapeutic strategies for schizophrenia. Schizophrenia Res. 1991;4: 121–156.
10. Kane J, Honigfeld G, Singer J, Meltzer H, and the Clozaril Collaborative Study Group. Clozapine for the treatment-resistant schizophrenic. Arch Gen Psychiatry. 1988;45: 789–796.
11. Meltzer HY, Matsubara S, Lee J-C. Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin-2 pKi values. J Pharmacol Exp Ther. 1989;251: 238–246.
12. Chiodo LA, Bunney BS. Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons. J Neurosci. 1983;3: 1607–1619.
13. Bunney BS. Effects of acute and chronic neuroleptic treatment on the activity of midbrain dopamine neurons. Ann NY Acad Sci. 1988;537: 77–85.
14. Seeman P, Guan H-C, Van Tol HHM. Dopamine D4 receptors elevated in schizophrenia. Nature. 1993;365: 441–445.
15. Van Tol HHM, Caren MW, Guan H-C, et al. Multiple dopamine D4 receptor variants in the human population. Nature. 1992;358: 149–152.
16. Gelernter J, Kennedy J, van Tol HHM, Civelli O, Kidd KK. The D4 dopamine receptor (DRD4) maps to distal 11p close to HRAS. Genomics. 1992;13: 208–210.
17. Nielsen DA, Dean M, Goldman D. Genetic mapping of the human tryptophan hydroxylase gene on chromosome 11, using an intronic conformational polymorphism. Am J Hum Genet. 1992;51: 1366–1371.
18. Strader CD, Dixon RA, Cheung AH, Candelore MR, Blake AD, Sigal IS. Mutations that uncouple the βadrenergic receptor from Gs and increase agonist affinity. J Biol Chem. 1987;262: 16439–16443.
19. Kobilka BK, Kobilka TS, Daniel K, Regan JW, Caron MG, Lefkowitz RJ. Chimeric α-2- and β-2-adrenergic receptors: delineation of domains involved in effector coupling and ligand binding specificity. Science. 1988;240: 1310–1316.
20. Mansour A, Meng F, Meador-Woodruff JH, Taylor LP, Civelli O, Akil H. Sitedirected mutagenesis of the human dopamine D2 receptor. Eur J Pharmacol. 1992;227: 205–214.
21. Coon H, Byerley W, Holik J, et al. Linkage analysis of schizophrenia with five dopamine receptor genes in nine pedigrees. Am J Hum Genet 1993;52: 327–334.
22. Pickar D, Owen RR, Litman RE, Konicki PE, Gutierrez R, Rapaport MH. Clinical and biologic response to clozapine in patients with schizophrenia. Arch Gen Psychiatry. 1992;49: 345–353.
23. Lichter JB, Barr CL, Kennedy JL, Van Tol HHM, Kidd KK, Livak KJ. A hypervariable segment in the human dopamine receptor D4 (DRD4) gene. Hum Mol Genet. 1993;2: 767–773.
24. American Psychiatric Association, Committee on Nomenclature and Statistics. Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition. Washington, DC: American Psychiatric Association; 1987.
25. Overall JE, Gorham DR. The Brief Psychiatric Rating Scale. Psychol Rep. 1962;10: 799–812.
26. Bunney WE Jr, Hamburg DA. Methods for reliable longitudinal observation of behavior. Arch Gen Psychiatry. 1963;9: 280–294.
27. Sommer SS, Lind TJ, Heston LL, Sobell JL. Dopamine D4 receptor variants in unrelated schizophrenic cases and controls. Am J Med Genet. 1993;48: 90–93.
28. Gelernter J, O'Malley S, Risch N, et al. No association between an allele at the D2 dopamine receptor gene (DRD2) and alcoholism. JAMA. 1991;266: 1801–1807.
29. Gelernter J, Goldman D, Risch N. The A1 allele at the D2 dopamine receptor gene and alcoholism: a reappraisal. JAMA. 1993;269: 1673–1677.
30. Nanko S, Hattori M, Ikeda K, Sasaki T, kazamatsuri H, Kuwata S. Dopamine D4 receptor polymorphism and schizophrenia. Lancet. 1993;341: 689–690.
31. Seeman P. Dopamine receptor sequences: therapeutic levels of neuroleptics occupy D2 receptors, clozapine occupies D4. Neuropsychopharmacology. 1992;7: 261–284.
32. Catalano M, Nobile M, Novelli E, Nothen MM, Smeraldi E. Distribution of a novel mutation in the 1st exon of the human dopamine D4 receptor gene in psychotic patients. Biol Psychiatry. 1993;34: 459–464.
33. Gejman PV, Gelernter J. Mutational analysis of candidate genes in psychiatric disorders. Am J Med Genet. 1993;48: 184–191.
34. Kendler KS. The genetics of schizophrenia and related disorders: a review. In: Dunner DL, Gershon ES, Barrett JE. Relatives at Risk for Mental Disorder. New York, NY: Raven Press; 1988.
35. Van Rossum JM. The significance of dopamine-receptor blockade for the action of neuroleptic drugs. In: Brill H, Cole JO, Deniker P, Hippius H, Bradley PB, eds. Proceedings of the Fifth International Congress of the Collegium Internationale Neuropsychopharmacologicum. Amsterdam, the Netherlands: Exerpta Medica Foundation; 1967: 321–329.
36. Losonczy MF, Davidson M, Davis KL. The dopamine hypothesis of schizophrenia. In: Meltzer HY, ed. Psychopharmacology: The Third Generation of Progress. New York, NY: Raven Press; 1987: 715–726.
37. Moises HW, Gelernter J, Giuffra LA, et al. No linkage between D2-dopamine receptor gene region and schizophrenia. Arch Gen Psychiatry. 1991;48: 643–647.
38. Gelernter J, Kidd KK. The current status of linkage studies in schizophrenia. In: McHugh P, McKusick VA, eds. Brain and Behavior. New York, NY: Raven Press; 1990: 137–152.
39. Tandon R and Kane JM. Neuropharmacologic basis for clozapine's unique profile. Arch Gen Psychiatry. 1993;50: 158–159.
40. Monsma FJ, Shen Y, Ward RP, Hamblin MW, Sibley DR. Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs. Mol Pharmacol. 1993;43: 320–327.
41. Shen Y, Monsma FJ, Metcalf MA, Jose PA, Hamblin MW, Sibley DR. Molecular cloning and expression of a 5-hydroxytrypamine7 serotonin receptor subtype. J Biol Chem. 1993;268: 18200–18204.